article · Caryologia
Nanotechnology is widely gaining worldwide application in biology and medicine because of its proven efficacy. Annona muricata contains bioactive phytochemicals with an inherent ability to bio-fabricate metal ions nanoparticles (NPs). Annona muricata aqueous leaf extract and its green bio-fabricated silver nanoparticles were evaluated on red blood cells (RBC) for anti-haemolytic activity and cytogenotoxicity on Allium cepa cells. The effects of A. muricata extract (Am-E) and its biofabricated silver nanoparticles (Am-AgNPs) were observed at 0.7, 7.0 and 70.0 µg/ml on H2O2-induced haemolysis in RBC and cyclophosphamide-induced cytogenotoxicity on A. cepa cells. Results showed significant and concentration dependent anti-haemolytic activity of Am-E relative to Am-AgNPs. Significant (P<0.05) reduction of mitotic index was observed in the groups treated with Am-AgNPs compared with Am-E, which indicates cytotoxic effect of the nanoparticles. The Am-E protected A. cepa meristem root cells from cyclophosphamide-induced mitotic repression better than Am-AgNPs. Different degree of chromosomal abnormalities such as chromosome-bridge, sticky chromosome, and c-mitosis were observed in all the treatment groups with chromosome-bridge and sticky chromosome being prominent. This study revealed stronger anti-haemolytic efficacy of Am-E at higher concentrations compared with Am-AgNPs. Chromosomal abnormalities observed in this study suggest greater chromosomal instability as influenced by the nanoparticles compared with the extract on onion cells. The protective effect of the extract against cyclophosphamide-induced chromosomal aberrations may be an indication of its potential as an anti-genotoxic agent.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.36253/caryologia-1353
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.